Author Login IJIRT Partner Network (IPN) Login

OXCARBAZEPINE INDUCED HYPONATREMIA: A CASE REPORT

  • Unique Paper ID: 157252
  • Volume: 9
  • Issue: 6
  • PageNo: 365-367
  • Abstract:
  • Oxcarbazepine is a well-known and effective anti-convulsant used for patients with underlying seizure disorder. It is a structural analog of carbamazepine, it follows a different metabolic pathway in which it is converted to a different active metabolite. Side effects associated with this medication are vast, in this report we will look in on the renal adverse effects, Syndrome of inappropriate anti-diuretic hormone secretion (SiADH). SiADH is a condition in which the body is making too much anti-diuretic hormone which results in too much water absorption and cause hyponatremia with neurologic sequelae. Here is a 67-year-old female patient with complaint of increased talk, insomnia for 3 months. On admission in hospital under psychiatry the patient was treated with T.Zenoxa (Oxcarbazepine) 450mg 1-0-1 and on following days patient Na decreased 135, 130, 124 mEq/L which indicated to be hyponatremic secondary to having SiADH.
Download article email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 9
  • Issue: 6
  • PageNo: 365-367

OXCARBAZEPINE INDUCED HYPONATREMIA: A CASE REPORT

Related Articles

Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Archive

View More

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry